IL-32 expression upregulated in chronic rhinosinusitis

IL-32 expression upregulated in chronic rhinosinusitis
Interleukin-32 mRNA expression is significantly higher in biopsies obtained from patients with chronic rhinosinusitis, compared to levels found in biopsies obtained from individuals without the condition, according to a study published online April 9 in Allergy.

(HealthDay) -- Interleukin-32 (IL-32) mRNA expression is significantly higher in biopsies obtained from patients with chronic rhinosinusitis (CRS), compared to levels found in biopsies obtained from individuals without the condition, according to a study published online April 9 in Allergy.

Michael B. Soyka, M.D., of the Swiss Institute of Allergy and Asthma Research in Davos, and colleagues isolated human primary sinonasal epithelial cells (HSECs) from biopsies of patients with CRS and from healthy individuals and stimulated them with different cytokines. IL-32 was investigated and were determined.

The researchers found that tumor necrosis factor-α (TNF-α) and interferon-γ (IFN-γ) upregulated IL-32 mRNA expression in primary epithelial cells, but other interleukins tested did not influence IL-32 mRNA expression. In HSECs co-cultured with T-helper 1 cells (Th1), IL-32 was significantly higher than in cells co-cultured with Th0 or Th2 cells. Compared with healthy subjects, IL-32 mRNA expression was significantly higher in biopsies obtained from CRS patients with nasal polyps (CRSwNP). Compared with control tissues, in patients with CRS, IL-32 was detected in biopsies.

"In conclusion, our study demonstrates that IL-32 might be involved in the pathogenesis of CRS," the authors write. "The induction of IL-32 in HSECs and sinonasal biopsies by Th1 cells, TNF-α, and IFN-γ and the upregulation of IL-32 in CRSwNP indicate a potentially important role of this cytokine."

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Vitamin D analogs modulate immunity in psoriasis

Mar 09, 2012

(HealthDay) -- Vitamin D3 analogs modulate immunity in human psoriasis, inducing thymic stromal lymphopoietin (TSLP) and cathelicidin, according to a study published online March 2 in the British Journal of ...

Probiotics reduce infections for patients in intensive care

Dec 02, 2011

Traumatic brain injury is associated with a profound suppression of the patient's ability to fight infection. At the same time the patient also often suffers hyper-inflammation, due to the brain releasing glucocorticoids ...

Recommended for you

Protein linked to development of asthma

Feb 20, 2015

Researchers at the Medical College of Wisconsin (MCW) have linked a specific protein to the development of post-viral infection asthma, which is the first step in generating a novel type of asthma therapy designed to prevent ...

Researchers offer new target for treating asthma

Feb 18, 2015

Researchers have found a potential new target for treating asthma, according to a study led by researchers at the University of Colorado School of Medicine at the Anschutz Medical Campus and published in the journal Nature Co ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.